Mutant Prevention Concentrations of Levofloxacin Alone and in Combination with Azithromycin, Ceftazidime, Colistin (Polymyxin E), Meropenem, Piperacillin-Tazobactam, and Tobramycin against Pseudomonas aeruginosa-Reference-Cited by-同舟云学术

Mutant Prevention Concentrations of Levofloxacin Alone and in Combination with Azithromycin, Ceftazidime, Colistin (Polymyxin E), Meropenem, Piperacillin-Tazobactam, and Tobramycin against Pseudomonas aeruginosa

Published:2006-06 Issue:6 Volume:50 Page:2228-2230
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Zhanel George G.¹²³,Mayer Matthew⁴,Laing Nancy¹,Adam Heather J.¹³

Affiliation:

1. Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada;

2. Departments of Medicine

3. Clinical Microbiology, Health Sciences Centre, Winnipeg, Manitoba, Canada

4. Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada

Abstract

ABSTRACT The mutant prevention concentrations (MPCs) of levofloxacin alone and in combination with ceftazidime, colistin (polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin were established against Pseudomonas aeruginosa. Antibiotic combinations using levofloxacin with any antibiotic with individual activity against P. aeruginosa resulted in synergistic lowering (an at-least-fourfold reduction) of the isolate's MPC.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.01620-05

Reference11 articles.

1. Drlica, K. 2003. The mutant selection window and antimicrobial resistance. J. Antimicrob. Chemother.52:11-17.

2. Firsov, A. A., S. N. Vostrov, I. Y. Lubenko, Y. A. Portnoy, and S. H. Zinner. 2004. Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination. Int. J. Antimicrob. Agents23:451-456.

3. In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus

4. A Review of Streptococcus pneumoniae Infection Treatment Failures Associated with Fluoroquinolone Resistance

5. Kucers A. S. Scrowe M. L. Grayson and J. Hoy. 1997. The use of antibiotics: a clinical review of antibacterial antifungal and antiviral drugs 5th ed. Butterworth-Heinemann Boston Mass.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of an amoxicillin-radix scutellaria extract formulation and evaluation of its pharmacokinetics in pigs;BMC Veterinary Research;2023-09-19

2. Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae;ACS Infectious Diseases;2023-09-05

3. Synergistic Activity of Cyclo(phe-pro) Antibiotic from Streptomyces violascens VS in Reducing the Drug Resistance Burden of Clinically Significant Pathogens;Journal of Biologically Active Products from Nature;2022-11-02

4. Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa : A case control study with time kill curve analysis;Annals of Medicine & Surgery;2022-10

5. Drug Combinations to Prevent Antimicrobial Resistance: Various Correlations and Laws, and Their Verifications, Thus Proposing Some Principles and a Preliminary Scheme;Antibiotics;2022-09-20